simendan has been researched along with Shock in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Alkhulaifi, A; Caliskan, K; Elsherbini, H; Ibrahim, MIM; Kaddoura, R; Lorusso, R; Omar, AS; Soliman, O | 1 |
Dempsey, E; Rabe, H | 1 |
Kurola, J; Rapola, J; Sallisalmi, M; Varpula, T | 1 |
Noori, S; Seri, I | 1 |
3 review(s) available for simendan and Shock
Article | Year |
---|---|
The Effectiveness of Levosimendan on Veno-Arterial Extracorporeal Membrane Oxygenation Management and Outcome: A Systematic Review and Meta-Analysis.
Topics: Aged; Cardiac Surgical Procedures; Extracorporeal Membrane Oxygenation; Humans; Middle Aged; Randomized Controlled Trials as Topic; Shock; Shock, Cardiogenic; Simendan | 2021 |
The Use of Cardiotonic Drugs in Neonates.
Topics: Adrenal Cortex Hormones; Asphyxia Neonatorum; Cardiotonic Agents; Dobutamine; Dopamine; Heart Defects, Congenital; Humans; Hypotension; Infant, Newborn; Intensive Care Units, Neonatal; Milrinone; Neonatal Sepsis; Norepinephrine; Persistent Fetal Circulation Syndrome; Shock; Simendan; Vasoconstrictor Agents; Vasopressins | 2019 |
Neonatal blood pressure support: the use of inotropes, lusitropes, and other vasopressor agents.
Topics: Cardiotonic Agents; Cardiovascular System; Dobutamine; Dopamine; Epinephrine; Hemodynamics; Humans; Hydrazones; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Milrinone; Pyridazines; Shock; Simendan; Vasoconstrictor Agents; Vasopressins | 2012 |
1 other study(ies) available for simendan and Shock
Article | Year |
---|---|
Treatment of serious calcium channel blocker overdose with levosimendan, a calcium sensitizer.
Topics: Acidosis, Lactic; Amlodipine; Calcium Channel Blockers; Cardiotonic Agents; Coma; Drug Overdose; Echocardiography; Epinephrine; Female; Hemodynamics; Humans; Hydrazones; Male; Middle Aged; Pyridazines; Shock; Simendan; Vasoconstrictor Agents; Verapamil | 2009 |